Literature DB >> 4945248

Polyvinylpyrrolidone (PVP), its diagnostic, therapeutic and technical application and consequences thereof.

W Wessel, M Schoog, E Winkler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4945248

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN： 0004-4172


× No keyword cloud information.
  9 in total

Review 1.  Reactive impurities in excipients: profiling, identification and mitigation of drug-excipient incompatibility.

Authors:  Yongmei Wu; Jaquan Levons; Ajit S Narang; Krishnaswamy Raghavan; Venkatramana M Rao
Journal:  AAPS PharmSciTech       Date:  2011-09-27       Impact factor: 3.246

Review 2.  Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Authors:  L K Golightly; S S Smolinske; M L Bennett; E W Sutherland; B H Rumack
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

3.  Modulation of RNA transport by polyvinylpyrrolidone.

Authors:  G A Clawson; J Button; C H Woo; E A Smuckler
Journal:  Mol Biol Rep       Date:  1984-12       Impact factor: 2.316

4.  The effect of coumarin on protein and PVP clearance from rat legs with various high protein oedemas.

Authors:  N B Piller; J R Casley-Smith
Journal:  Br J Exp Pathol       Date:  1975-10

5.  Chronic Kidney Disease from Polyvinylpyrrolidone Deposition in Persons with Intravenous Drug Use.

Authors:  Ida V Stalund; Heidi Grønseth; Finn P Reinholt; Einar Svarstad; Hans-Peter Marti; Sabine Leh
Journal:  Clin J Am Soc Nephrol       Date:  2022-03-16       Impact factor: 8.237

Review 6.  Pharmaceutical assessment of polyvinylpyrrolidone (PVP): As excipient from conventional to controlled delivery systems with a spotlight on COVID-19 inhibition.

Authors:  Mallesh Kurakula; G S N Koteswara Rao
Journal:  J Drug Deliv Sci Technol       Date:  2020-09-02       Impact factor: 3.981

7.  Evaluation of polyethylene oxide compacts as gastroretentive delivery systems.

Authors:  Ravichandran Mahalingam; Bhaskara Jasti; Raj Birudaraj; Dimitrios Stefanidis; Robert Killion; Tom Alfredson; Pratap Anne; Xiaoling Li
Journal:  AAPS PharmSciTech       Date:  2009-01-16       Impact factor: 3.246

8.  Pharmacokinetic disposition of the novel atypical anxiolytic CGS 9896 in the cynomolgus monkey.

Authors:  G M Kochak; A Rakhit; F Honc; C J Mahoney
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

9.  Case Report: Polyvinylpyrrolidone deposition disease from repeated injection of opioid substitution drugs: report of a case with a fatal outcome.

Authors:  Ida Viken Stalund; Gro Nygard Riise; Friedemann Leh; Tormod Karlsen Bjånes; Lars Riise; Einar Svarstad; Sabine Leh
Journal:  F1000Res       Date:  2021-04-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.